American Commitment responded to the request for comments regarding addressing foreign nations freeloading on American-financed innovation. Here is a sampling of that letter, and you can read the full letter here.
To Whom It May Concern:
American Commitment is a public policy advocacy group dedicated to restoring and protecting the American Commitment to free markets, economic growth, Constitutionally-limited government, property rights, and individual freedom.
We strongly urge the Trump administration to reject the so-called “Most FavoredNation” (MFN) drug pricing model.
The White House’s May 12 Executive Order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” rightfully identifies the global inequity in drug pricing. 1 Other rich countries use price controls to get a free ride on innovation that is driven by returns on capital in the United States market, a genuine problem that if effectively addressed would likely result in more new drugs developed and lower prices. This problem cannot, however, be addressed by simply linking US prices to foreign prices, which would leave no moving vehicle of innovation for anyone to ride, free or otherwise…